
    
      Two treatment options were compared - health facility and community DOT. In 1995, Ethiopia
      adopted World Health Organization (WHO) recommended DOTS strategy for TB control. The
      treatment regimen for new smear-positive patients includes two months of ethambutol,
      rifampicin, isoniazid and pyrazinamide followed by six months of ethambutol and isoniazid.
      For children the continuation phase treatment was replaced by four months of rifampicin and
      isoniazid. Follow up sputum examinations were conducted at the end of 2, 5 and 7 months
      treatment.
    
  